Treatment, Medication & Supplement Directory
A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.
Named profile Baituxiao Botanical Formula: Product, Label and Evidence ProfileRepresentative category illustration – no product packaging is shown.Baituxiao Botanical Formula: Product, Label and Evidence Profile
Baituxiao is marketed as a botanical supplement for pet wellness, comfort, vitality and normal immune function. It is not an FDA-approved cancer drug, and the manufacturer's own disclaimer…
Read more
Appetite Support: Find and Treat the Reason a Dog Is Not Eating
Reduced appetite can result from nausea, pain, fever, constipation, oral disease, swallowing difficulty, medication effects, tumor location, stress, or metabolic illness. Appetite support starts by investigating and treating…
Read more
Omega-3 Fatty Acid Support: Product, Dose, and Evidence Questions
Omega-3 products are nutritional supplements, not cancer treatments. EPA and DHA content, total calories, oxidation control, formulation, and quality vary widely, and evidence from one condition or diet…
Read more
Mirtazapine for Appetite Support: Nausea-First and Interaction Boundary
Mirtazapine may support appetite in selected dogs or cats, but nausea, pain, obstruction, oral disease, diet, organ function, and serotonergic interactions need attention first.
Read moreCapromorelin for Appetite Support: Cause, Species, and Monitoring
Capromorelin is a ghrelin-receptor agonist used in species- and product-specific veterinary appetite settings; it does not replace evaluation of why intake fell.
Read more
Medicinal Mushroom Extracts: Product-Specific Oncology Evidence
Mushroom products differ by species, extracted fraction, standardization, contaminants, and evidence; the word mushroom does not identify a tested intervention.
Read moreTurmeric and Curcumin: Bioavailability, Interaction, and Evidence Limits
Turmeric and curcumin products vary in extract, concentration, absorption enhancers, and purity, while robust canine cancer outcome evidence is lacking.
Read moreCBD and Cannabis Products in Pets With Cancer: Regulatory and Safety Boundary
FDA has not approved CBD for animal use, and product quality, THC contamination, interactions, liver effects, sedation, legal status, and cancer claims require caution.
Read moreChinese Herbal Formulas: Identification, Quality, and Evidence Review
A named traditional formula can vary by translation, ingredient, species, processing, manufacturer, and practitioner modification, so exact identification comes before benefit or safety claims.
Read moreProbiotics and Synbiotics During Cancer Treatment: Strain-Specific Evidence
Probiotic effects are strain-, combination-, product-, storage-, and condition-specific, and immune compromise changes the safety conversation.
Read more
Veterinary Acupuncture in Cancer Support: Symptom-Focused Evidence Boundary
Acupuncture may be discussed as an adjunct for selected pain, nausea, mobility, or wellbeing goals, but veterinary oncology-specific clinical evidence is limited.
Read moreNamed profile Jing Tang Stasis Breaker: Veterinary Product ProfileRepresentative category illustration – no product packaging is shown.Jing Tang Stasis Breaker: Veterinary Product Profile
Jing Tang Stasis Breaker is a named herbal formula for Dogs and cats; the current manufacturer page also lists horses; manufacturer positioning must be kept separate from independent…
Read more